ONCOLOGÍA CELULAR
Hospital Universitari de Bellvitge
l'Hospitalet de Llobregat, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitari de Bellvitge (9)
2021
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
-
SEOM clinical guideline for management of adult medulloblastoma (2020)
Clinical and Translational Oncology, Vol. 23, Núm. 5, pp. 940-947
2017
-
Consensus guidelines for diagnosis, treatment and follow-up of patients with pancreatic cancer in Spain
Clinical and Translational Oncology, Vol. 19, Núm. 6, pp. 667-681
-
Relationship between drugs affecting the renin-angiotensin system and colorectal cancer: The MCC-Spain study
Preventive Medicine, Vol. 99, pp. 178-184
-
Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition
Oncogene, Vol. 36, Núm. 19, pp. 2737-2749
2016
-
High Body Mass Index as a Risk Factor for Hospitalization Due to Influenza: A Case-Control Study
Archivos de Bronconeumologia, Vol. 52, Núm. 6, pp. 299-307
2010
-
A Novel PRNP Y218N mutation in gerstmann-sträussler-scheinker disease with neurofibrillary degeneration
Journal of Neuropathology and Experimental Neurology, Vol. 69, Núm. 8, pp. 789-800
2009
-
Neuropathology of Parkinson's disease with the R1441G mutation in LRRK2
Movement Disorders, Vol. 24, Núm. 13, pp. 1998-2001
2008
-
Mutations in Progranulin Gene: Clinical, Pathological, and Ribonucleic Acid Expression Findings
Biological Psychiatry, Vol. 63, Núm. 10, pp. 946-952